Imaging and Physiologic Evaluation of Coronary Artery Disease
1 other identifier
observational
2,000
1 country
1
Brief Summary
To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease (CAD) undergoing invasive coronary angiography (ICA), intravascular imaging, or invasive physiologic assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2021
CompletedFirst Submitted
Initial submission to the registry
November 4, 2021
CompletedFirst Posted
Study publicly available on registry
November 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
March 18, 2026
March 1, 2026
8.2 years
November 4, 2021
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MACE
a composite of all-cause death, myocardial infarction, or any revascularization
3-Year after the index procedure
Secondary Outcomes (10)
Rate of all-cause death
3-Year after the index procedure
Rate of cardiac death
3-Year after the index procedure
Rate of myocardial infarction
3-Year after the index procedure
Rate of target lesion revascularization
3-Year after the index procedure
Rate of target vessel revascularization
3-Year after the index procedure
- +5 more secondary outcomes
Study Arms (2)
Invasive coronary angiography (ICA)
Patients who undergoing invasive coronary angiography with intravascular imaging or invasive physiologic assessment
Percutaneous coronary intervention (PCI)
Patients who undergoing percutaneous coronary intervention with intravascular imaging or invasive physiologic assessment
Interventions
Intravascular imaging (IVUS or OCT) or Invasive physiologic assessment
Eligibility Criteria
About 2,000 patients with suspected ischemic heart disease and underwent ICA, intravascular imaging, or invasive physiologic assessment
You may qualify if:
- Subject must be at least 18 years of age
- Subjects who suspected ischemic heart disease and underwent ICA.
- Subjects who were performed intravascular imaging or invasive physiologic assessment
You may not qualify if:
- Subject with Age \<18 years
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chonnam National University Hospital
Gwangju, 61469, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Young Joon LeeHong, MD, PhD
Chonnam National University Medical School; Chonnam National University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
November 4, 2021
First Posted
November 17, 2021
Study Start
November 1, 2021
Primary Completion (Estimated)
December 31, 2029
Study Completion (Estimated)
December 31, 2030
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- 1 year after study completion
After publication of first manuscript and trial results, the de-identified data will be shared by permission of principle investigator, when asked.